» Authors » O Kaipiainen-Seppanen

O Kaipiainen-Seppanen

Explore the profile of O Kaipiainen-Seppanen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 42
Citations 323
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Paltta J, Heikkila H, Pirila L, Eklund K, Huhtakangas J, Isomaki P, et al.
Scand J Rheumatol . 2021 Oct; 52(1):1-9. PMID: 34643165
Objective: The aim of this study was to determine the validity of rheumatoid arthritis (RA) diagnoses in patients participating in Finnish biobanks. Method: We reviewed the electronic medical records of...
2.
Hiltunen J, Parmanne P, Sokka T, Lamberg T, Isomaki P, Kaipiainen-Seppanen O, et al.
Rheumatol Int . 2021 Aug; 42(6):1015-1025. PMID: 34357455
Considerable proportion of patients with SpA have been immunized to the subcutaneous anti-TNF drug they are using. Concomitant use of MTX protects from immunization, whereas SASP does not. Patients with...
3.
Kononoff A, Horkko S, Pussinen P, Kautiainen H, Elfving P, Savolainen E, et al.
Scand J Rheumatol . 2020 Sep; 50(2):113-117. PMID: 32985314
:To assess antibodies to malondialdehyde-acetaldehyde-modified low-density lipoprotein (MAA-LDL) in patients with newly diagnosed inflammatory joint disease.: Patients with rheumatoid arthritis (RA), spondyloarthritis (SpA), and undifferentiated arthritis (UA), participating in the...
4.
Kononoff A, Arstila L, Pussinen P, Kautiainen H, Elfving P, Savolainen E, et al.
Rheumatol Int . 2017 Aug; 37(10):1693-1700. PMID: 28791449
The objective of the study was to assess the incidence of inflammatory joint diseases and possible environmental factors contributing to their occurrence in a defined population in Finland. All rheumatologists...
5.
Elfving P, Marjoniemi O, Niinisalo H, Kononoff A, Arstila L, Savolainen E, et al.
Rheumatol Int . 2016 Apr; 36(7):917-24. PMID: 27053177
Objective of the study was to evaluate the annual incidence and distribution of autoimmune connective tissue diseases and vasculitides during 2010. All units practicing rheumatology in the Northern Savo area,...
6.
Elfving P, Puolakka K, Kautiainen H, Virta L, Pohjolainen T, Kaipiainen-Seppanen O
Lupus . 2016 Jan; 25(6):666-70. PMID: 26821964
The objectives of the study were to examine the initial, first-year anti-rheumatic outpatient therapy in patients with incident SLE, as well as the concomitant use of drugs for certain comorbidities,...
7.
Kuusalo L, Puolakka K, Kautiainen H, Blafield H, Eklund K, Ilva K, et al.
Scand J Rheumatol . 2015 Sep; 44(6):449-55. PMID: 26324784
Objectives: It is well recognized that medication adherence of rheumatoid arthritis (RA) patients is often poor. As less attention has been paid to physicians' adherence to targeted treatment, we aimed...
8.
Elfving P, Puolakka K, Kautiainen H, Virta L, Pohjolainen T, Kaipiainen-Seppanen O
Lupus . 2014 Jul; 23(13):1430-4. PMID: 25057036
The objectives of the study were to investigate mortality and causes of death in patients with recent-onset systemic lupus erythematosus (SLE) in Finland. Data for patients with SLE for the...
9.
Rutanen J, Kononoff A, Arstila L, Elfving P, Koskela H, Kaipiainen-Seppanen O
Scand J Rheumatol . 2014 Mar; 43(3):254-6. PMID: 24650220
No abstract available.
10.
Savolainen E, Kettunen A, Narvanen A, Kautiainen H, Karkkainen U, Luosujarvi R, et al.
Scand J Rheumatol . 2009 Mar; 38(5):353-6. PMID: 19296404
Objective: To study the prevalence of different serotypes of Chlamydia trachomatis antibodies and the incidence of C. trachomatis-induced reactive arthritis (ReA) among patients with early arthritis in a defined population....